Immune imbalance and immune modulation in solid tumor patients: new insights

Half-Life and Precision Shape Measurement of the 2νββ Decay of ^{130}Te.

Physical review letters·2025

Search for Fractionally Charged Particles with CUORE.

Physical review letters·2025

Erratum: Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE [Phys. Rev. Lett. 126, 171801 (2021)].

Physical review letters·2024

New Direct Limit on Neutrinoless Double Beta Decay Half-Life of ^{128}Te with CUORE.

Physical review letters·2022

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery.

ESMO open·2021

Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE.

Physical review letters·2021

Future Challenges of Molecular Imaging in Oncology.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Clinical Applications of Theranostics.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Internal Radiation Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

The Role of Molecular Imaging in Ion Beam Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Molecular Imaging in Photon Radiotherapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Advancements in Intraoperative Imaging for Enhanced Surgical Precision.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Frontiers in oncology·2026

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Nature reviews. Cancer·2026

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Clinical rheumatology·2026

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

JTO clinical and research reports·2026

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Cancer research·2026

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Frontiers in microbiology·2026

Related Experiment Videos

Immune imbalance and immune modulation in solid tumor patients: new insights

Related Concept Videos

Half-Life and Precision Shape Measurement of the 2νββ Decay of ^{130}Te.

Search for Fractionally Charged Particles with CUORE.

Erratum: Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE [Phys. Rev. Lett. 126, 171801 (2021)].

New Direct Limit on Neutrinoless Double Beta Decay Half-Life of ^{128}Te with CUORE.

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery.

Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE.

Future Challenges of Molecular Imaging in Oncology.

Clinical Applications of Theranostics.

Internal Radiation Therapy.

The Role of Molecular Imaging in Ion Beam Therapy.

Molecular Imaging in Photon Radiotherapy.

Advancements in Intraoperative Imaging for Enhanced Surgical Precision.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Related Experiment Videos

Immune imbalance and immune modulation in solid tumor patients: new insights

Related Concept Videos

Related Articles